EU regulator finds no safety issues with GSK, Merck HPV vaccines

LONDON, Nov 5 (Reuters) - European drug regulators have found no safety concerns linking GlaxoSmithKline's and Merck's cervical cancer vaccines with two conditions known as complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS).